Commands a premium valuation multiple over its peers, likely pricing in superior execution.
High-quality fundamentals with a strong composite quality score of 80/100, backed by robust profitability and solvency.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: High-quality compounder, with growth as the only relative weakness.
Wall Street sentiment is generally neutral. The company currently retains all capital for reinvestment and growth rather than returning it to shareholders.
EGG exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins. This is backed by a fortress balance sheet, holding significant net cash ($9M) and minimal debt risk.
The company demonstrates solid revenue growth (6.2% 3Y CAGR) paired with highly explosive earnings growth (46.8% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 44.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | -14.7% | +6.2% | — | — | |
| EBITDA | $625K | — | +12.5% | — | — | |
| Net Income | $617K | -48.2% | +45.6% | — | — | |
| EPS (Diluted) | $0.02 | -46.9% | +46.8% | — | — | |
| Free Cash Flow | $0.00 | -146.0% | -63.0% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 74.4% | 67.7% | 55.5% | 55.5% |
| Operating Margin | 44.2% | 23.3% | 10.8% | 10.8% |
| Net Margin | 40.0% | 19.3% | 8.5% | 8.5% |
| FCF Margin | 3.5% | -20.2% | -19.8% | -19.8% |
Total return is +155.0% (1Y), outperforming the benchmark by +134.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +39.4% | +32.1% | — |
| 1Y | +155.0% | +134.2% | — |
| 3YCAGR | +5.2% | -15.8% | — |
| 5YCAGR | +3.1% | -9.4% | — |
| 10YCAGR | +1.5% | -12.7% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Enigmatig Limited (EGG) valuation, health, and returns.
Based on peer relative multiples, Enigmatig Limited appears Expensive versus peers compared to industry peers.
Enigmatig Limited has multiple valuation anchors: Peer Relative Fair Value: $0.72. A convergence of these signals offers higher conviction.
Enigmatig Limited displays excellent financial health with a composite quality score of 80/100, supported by a Altman Z-Score of 77.6 (safe zone), Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of 18.3%.
Enigmatig Limited does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Enigmatig Limited's current growth trajectory is Decelerating. The company achieved -14.7% 1Y revenue growth and -46.9% 1Y EPS growth, compared to its 3Y revenue CAGR of +6.2%.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for Enigmatig Limited include: -61.5% 1-year max drawdown, high beta (1.54x market volatility). Volatility risk is characterized by a beta of 1.54x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.